Instalab
logoInstalab

Testosterone

Saliva Test
See the active, usable share of your testosterone without a needle, tracked best as a trend over time.
4.8 (2,138 reviews)
Tested by Doctor's Data
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Self-collect at home
Kit shipped directly to you
Get results
Explained with clear next steps, no medical jargon

Should you take a Testosterone test?

This test is most useful if any of these apply to you.

Healthy but Want to Stay Ahead
You want a needle-free way to build a baseline and watch your active testosterone trend over time before any symptoms appear.
Noticing Signs of Low Testosterone
Low libido, fatigue, or lost strength has you wondering about the free, usable fraction your standard blood total may not reveal.
Dealing With PCOS or Irregular Cycles
Acne, unwanted hair, or irregular periods point to androgen excess, and this offers a non-invasive read on your active testosterone.
Training Hard and Tracking Recovery
You push your body and want to follow your androgen trend and recovery balance with easy, repeatable at-home samples.

About Testosterone

In your blood, most of your testosterone is locked to carrier proteins and cannot do anything. Only a small free slice can enter your cells and act on your muscles, brain, and bones, and that is the slice a saliva test tends to capture.

This is a newer, research-stage measurement without agreed-upon cutoffs, so a single number should not drive any decision. Its real strength is that it is easy to collect at home and repeat, which makes it well suited to watching your own trend.

What This Test Captures

Only about 1 to 3% of your testosterone circulates free and usable; the rest is bound to carrier proteins. That free fraction passively diffuses into saliva, which is why salivary testosterone (testosterone measured in spit) can track your free, active hormone more closely than the total number on a standard blood panel, though this holds most reliably when the sample is measured with a precise lab technique like mass spectrometry rather than a simpler immunoassay, where the link is only modest.

This matters most when carrier proteins are abnormal. Obesity, liver disease, and some infections change the level of a carrier protein called SHBG (sex hormone binding globulin), which can make total blood testosterone look normal even when the active fraction is low. Saliva sidesteps that problem in theory, though the salivary glands can do some of their own processing that blurs the signal.

Low Testosterone in Men

Low testosterone travels with obesity, less muscle, worse blood sugar control, reduced insulin sensitivity, unfavorable cholesterol, and in some groups higher heart disease risk, depression, and lower survival. Those links come from blood testosterone studies, and saliva reflects the same free hormone the studies were ultimately about.

Kidney disease is where saliva has been tested most directly. In advanced kidney disease, a study-defined saliva threshold correctly identified about 74 out of 100 men with deficiency and correctly cleared about 78 out of 100 without it. In a selected dialysis group with low libido, morning saliva testosterone matched blood free testosterone almost exactly.

Androgen Excess and PCOS in Women

A high result signals androgen excess, best established in polycystic ovary syndrome (PCOS), a common hormonal condition. Salivary testosterone runs higher in women with PCOS than without, and in research settings it performs about as well as standard androgen indexes for spotting the classic PCOS pattern, especially when measured by mass spectrometry (a highly precise lab technique). Even so, current international PCOS guidelines still recommend serum total and free testosterone as the first-line tests, not saliva.

Why this is worth knowing: the androgen excess in PCOS travels with real metabolic risk, including impaired glucose handling, type 2 diabetes, fatty liver disease, and cardiovascular disease. Pilot work in adolescents suggests salivary testosterone may help flag PCOS early, even in girls who are not overweight.

Mood, Cognition, and Behavior

Salivary testosterone shows human associations beyond the reproductive system, though these are correlations, not proof. In a cohort of about 2,100 people, women with depression, generalized anxiety, social phobia, or agoraphobia had lower salivary testosterone, while antidepressant (SSRI) users had higher levels.

The direction of these links depends on who is being studied. In older adults, women with higher salivary testosterone had a lower rate of mild memory impairment (roughly 26% lower per one standard step up in level), with a similar but non-significant trend in men. Yet in fathers, higher salivary testosterone tracked with higher child-abuse risk and less positive parenting, and in male psychiatric inpatients high testosterone predicted aggression only when cortisol was also low.

These findings can look contradictory: higher testosterone appears protective in one setting and unfavorable in another. The resolution is that salivary testosterone is not a simple good-number or bad-number marker. It is a context indicator, where the same level carries different meaning depending on sex, cortisol, life stage, and the specific question being asked, which is exactly why a lone reading cannot be labeled universally good or bad.

Why Timing Changes the Number So Much

Testosterone follows a daily rhythm, highest in the early morning and falling through the day. In men aged 30 to 40, levels ran roughly 20 to 25% lower in late afternoon than early morning, enough that some afternoon low results turn out normal on a morning retest; the swing shrinks with age, to about 10% by age 70.

Age and body fat also pull the number down. Classic androgens decline with age, and salivary testosterone shows a strong, independent drop as body mass index rises in men, so obesity can mimic deficiency. In premenopausal women, the phase of the menstrual cycle shifts levels too. The practical rule is to compare only like with like: same time of day, same collection method.

Why One Reading Is Not Enough

This is a research-stage measurement without standardized cutoffs, and it fluctuates enough that a single spit sample can mislead. Week-to-week within-person variation for testosterone is about 16%, and one sample can land anywhere from roughly 65% to 153% of your true average. Averaging two samples cuts that uncertainty by about 30%, and three by about 43%.

So the value is in the trajectory, not the dot. Get a morning baseline, ideally pooling a couple of samples, retest in 3 to 6 months if you are making changes, and at least annually after that. Because this marker is newer, building your own baseline now gives you personal data to compare against as the science matures.

When Results Can Be Misleading

  • Assay method: mass spectrometry is far more accurate than the direct immunoassays and ELISA kits many products use, especially at the low levels seen in women, so the lab's technique can change the number for the same sample.
  • Collection errors: food, drink, tooth brushing, or bleeding gums can contaminate a sample, and too little saliva can void it; different collection tubes give different readings, and some cotton-swab devices even create a falsely high result.
  • Recent intense exercise: hard exercise can transiently raise saliva testosterone right afterward and for up to 30 minutes, then it normalizes, while prolonged heavy training can instead suppress it for up to 72 hours; neither reflects a lasting change.
  • Testosterone gels: transdermal testosterone can push salivary readings far above physiologic levels with no relation to how you feel, so saliva should not be used to monitor gel-based therapy.

What to Do With an Unexpected Result

A single out-of-pattern saliva result is a prompt to investigate, not to act. The most useful next step is confirmation in blood: a fasting, early-morning serum total testosterone, repeated on a separate morning, because a single low blood value often fails to repeat. If the total is borderline or your carrier proteins may be off due to obesity, liver, or thyroid disease, add free testosterone and SHBG.

Combinations matter more than any single number. Low testosterone plus symptoms plus a low LH (luteinizing hormone, the pituitary signal to the testes) points toward a central cause, while low testosterone with high LH points to the testes themselves. For suspected androgen excess, pairing an elevated result with androstenedione, AMH, and clinical signs sharpens the PCOS picture. Persistent, confirmed abnormalities are worth taking to an endocrinologist, or a gynecologist for suspected PCOS, and saliva alone should never be used to start or dose testosterone therapy.

What Moves This Biomarker

Evidence-backed interventions that affect your Testosterone level

Increase
Prescription testosterone (injectable)
Prescription testosterone genuinely raises your testosterone, and injectable testosterone undecanoate has been shown to raise salivary testosterone in step with blood levels, capturing large peaks 7 to 14 days after an injection. This treats true deficiency, but transdermal gels are a trap for saliva testing: they can push salivary readings far above physiologic levels without matching how you feel, so saliva should not be used to monitor gel-based therapy.
MedicationStrong Evidence
Increase
Aromatase inhibitor (anastrozole) with weight loss
Adding an aromatase inhibitor, which blocks the conversion of testosterone into estrogen, to a weight-loss program raised testosterone and lowered estradiol over 6 months. In a randomized trial of 23 severely obese men, the drug-plus-weight-loss group ended with higher testosterone than weight loss plus placebo. This used blood testosterone, and aromatase inhibitors are prescription-only with specific indications, not a routine option.
MedicationStrong Evidence
Increase
Lose excess body fat
Shedding excess body fat raises the free testosterone your tissues can use, because fat tissue actively drives testosterone down in a self-reinforcing loop. Studies in men with obesity show that weight loss increases testosterone and that obesity is one of the strongest reversible causes of low levels. These measurements used blood testosterone; saliva reflects the same free hormone but has not been tracked in the same weight-loss trials.
LifestyleModerate Evidence
Increase
GLP-1 receptor agonists (liraglutide, semaglutide)
The weight-loss and diabetes drugs in the GLP-1 class can raise testosterone in men with obesity-related low levels. A systematic review found liraglutide markedly increased total testosterone and the carrier protein SHBG in obese men with low testosterone, while semaglutide produced more modest rises and some agents produced none. All of this used blood, not saliva, and the effect appears in obese men specifically rather than in everyone.
MedicationModerate Evidence
Increase
Clomiphene citrate
Clomiphene raises your own testosterone by prompting the brain to signal the testes harder, rather than supplying testosterone from outside, which preserves fertility. A meta-analysis found total testosterone rose by about 2.6 nmol/L on treatment, along with LH, FSH, SHBG, and estradiol. This is blood evidence; its effect on salivary testosterone specifically has not been directly measured.
MedicationModerate Evidence
Decrease
Statins
Statins modestly lower testosterone as a side effect of blocking cholesterol production, which is also a building block for hormones. In pooled randomized trials, statins lowered testosterone by about 0.66 nmol/L in men and 0.40 nmol/L in women with PCOS, which is a few percent of a typical level. This evidence comes from blood testosterone, and there was no sign that statins interfere with the test itself.
MedicationModest Evidence

Frequently Asked Questions

References

30 studies
  1. M. Mezzullo, Alessia Fazzini, a. Gambineri, G. Di Dalmazi, Roberta Mazza, C. Pelusi, V. Vicennati, R. Pasquali, U. Pagotto, F. FanelliClinical Chemistry and Laboratory Medicine (CCLM)2017
  2. Mark S Newman, Jaclyn Smeaton, G. Gillson, Azra JaferiFrontiers in Reproductive Health2026
  3. F. Khan-dawood, J. Choe, M. DawoodAmerican Journal of Obstetrics and Gynecology1984
  4. L. Schiffer, Punith Kempegowda, a. Sitch, J. Adaway, F. Shaheen, Andreas Ebbehoj, Sumitabh Singh, Malcom P Mctaggart, M. O'reilly, a. Prete, J. Hawley, B. Keevil, I. Bancos, a. Taylor, W. ArltEuropean Journal of Endocrinology2023